Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 19/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4773951 | 0.91 | TRPV1 (0.56) | TRPV1MEN1HTTBLMKMT2A | |
| SCHEMBL4773955 | 0.88 | TRPV1 (0.59) | TRPV1 | |
| SCHEMBL4780302 | 0.85 | TRPV1 (0.52) | TRPV1 | |
| SCHEMBL4779491 | 0.83 | TRPV1 (0.51) | TRPV1MEN1MAPK1HTTBLM | |
| SCHEMBL4778197 | 0.83 | KDM4E (0.53) | TRPV1 | |
| SCHEMBL4778071 | 0.82 | CCNE1 (0.46) | TRPV1 | |
| SCHEMBL4776171 | 0.81 | TRPV1 (0.47) | TRPV1 | |
| SCHEMBL4779514 | 0.81 | KDM4E (0.53) | TRPV1MEN1KMT2A | |
| SCHEMBL4777140 | 0.81 | TRPV1 (0.55) | TRPV1 | |
| SCHEMBL4780970 | 0.81 | TRPV1 (0.63) | TRPV1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | claimed |
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | disclosed |